Nearest biotech catalysts
The next dated event for each company, soonest first. Readout dates are the sponsor's own projection and move.
| Company | Ticker | Next catalyst | In days | Market cap | Runway |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | VRTX | — | 1 | $134.3B | — |
| Spyre Therapeutics, Inc. | SYRE | — | 2 | $9.2B | 16.4Q |
| TG Therapeutics, Inc. | TGTX | — | 2 | $8.8B | — |
| Rhythm Pharmaceuticals, Inc. | RYTM | — | 2 | $6.3B | 6.2Q |
| Sarepta Therapeutics, Inc. | SRPT | — | 2 | $2.0B | 140.5Q |
| Annexon, Inc. | ANNX | — | 2 | $662M | 4.4Q |
| Olema Pharmaceuticals, Inc. | OLMA | — | 2 | $655M | 10.0Q |
| BioNTech SE | BNTX | — | 3 | $22.1B | — |
| Apogee Therapeutics, Inc. | APGE | — | 3 | $8.4B | 13.6Q |
| CG Oncology Inc. | CGON | — | 3 | $5.7B | 22.2Q |
| Erasca, Inc. | ERAS | — | 3 | $5.3B | 9.9Q |
| Vir Biotechnology, Inc. | VIR | — | 3 | $2.0B | 58.3Q |
| Tyra Biosciences, Inc. | TYRA | — | 3 | $1.3B | 11.4Q |
| Precigen, Inc. | PGEN | — | 13 | $2.2B | 2.1Q |
| Arvinas, Inc. | ARVN | — | 32 | $490M | 11.8Q |
| Madrigal Pharmaceuticals, Inc. | MDGL | — | 33 | $10.0B | — |
| Krystal Biotech, Inc. | KRYS | — | 33 | $9.5B | — |
| Abivax S.A. | ABVX | — | 33 | $7.7B | 7.4Q |
| Axsome Therapeutics, Inc. | AXSM | — | 33 | $7.5B | 9.7Q |
| Denali Therapeutics Inc. | DNLI | — | 33 | $3.1B | 7.3Q |
| Beam Therapeutics Inc. | BEAM | — | 33 | $3.0B | 17.4Q |
| Biohaven Ltd. | BHVN | — | 33 | $2.3B | 3.1Q |
| Arcus Biosciences, Inc. | RCUS | — | 33 | $2.3B | 5.9Q |
| BioCryst Pharmaceuticals, Inc. | BCRX | — | 33 | $2.1B | — |
| Omeros Corporation | OMER | — | 33 | $1.3B | — |
Nothing here is investment or medical advice.